Skip to content
Hydroxyamphetamine
Paredrine, Paremyd (hydroxyamphetamine) is a small molecule pharmaceutical. Hydroxyamphetamine was first approved as Paredrine on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydroxyamphetamine hydrobromide
Tradename
Company
Number
Date
Products
PAREDRINEPharmicsN-000004 DISCN1982-01-01
1 products
Hide discontinued
Hydroxyamphetamine hydrobromide
+
Tropicamide
Tradename
Company
Number
Date
Products
PAREMYDAkornN-019261 DISCN1992-01-30
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
paremydNew Drug Application2020-10-08
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
26 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MelanosisD008548EFO_0003963L81.1—347417
HyperpigmentationD017495—1—1—2
Skin pigmentationD012880EFO_0003784———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SepsisD018805A41.9——1——1
Septic shockD012772A48.3——1——1
HyperhomocysteinemiaD020138——1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Low back painD017116HP_0003419M54.5————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHYDROXYAMPHETAMINE
INNhydroxyamfetamine
Description
4-(2-aminopropyl)phenol is a member of amphetamines.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(N)Cc1ccc(O)cc1
Identifiers
PDB—
CAS-ID103-86-6
RxCUI—
ChEMBL IDCHEMBL1546
ChEBI ID—
PubChem CID3651
DrugBank—
UNII IDFQR280JW2N (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 385 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
777 adverse events reported
View more details